Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

GW Pharmaceuticals plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

Bank of American Corporation

4. Full name of shareholder(s)  (if different from 3.):

Merrill Lynch, Pierce, Fenner & Smith Incorporated

Citadel LLC

Bank of America Na

5. Date of the transaction and date onwhich the threshold is crossed orreached:

23rd April 2014

6. Date on which issuer notified:

25th April 2014

7. Threshold(s) that is/are crossed orreached:

Above 3%

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0030544687

(US36197T1034)

1 ADR = 12 shares

Below notifiable threshold

Below notifiable threshold

6,812,784

6,812,784

185,724

3.197%

0.087%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

% of voting rights

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,998,508 (583,209 ADRS)

3.284%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Merrill Lynch, Pierce, Fenner & Smith Incorporated 6,640,260 (3.116%)

Citadel LLC 357,072 (0.168%)

Bank of America Na 1,176 (0.001%)

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Szabina Biro

15. Contact telephone number:

0207 996 5648